melior discovery

About Us
Our Pipeline
Our Platform
Partnering with Us
Contact Us

Click here for the MLR-1023 non-confidential brochure          


Melior Pharmaceuticals identifies and develops new uses for small molecule therapeutics. By applying the proprietary theraTRACE® drug repositioning platform, Melior can rapidly evaluate compounds across multiple therapeutic areas. Once a new indication is identified, Melior will advance the drug through its own internal drug development program or with a strategic partner.

If you are interested in learning more about Melior Pharmaceuticals, please contact to start the conversation.


© 2008 Melior Discovery
home theraTRACE Melior Pharmaceuticals